Skip to content
Screener

Geron GERN Net Income

Net Income at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$3.32B+153%
Incyte logo
IncyteINCY
$585.61M+44.6%
Immunome logo
ImmunomeIMNM
-$53.84M-29.3%
Exelixis logo
ExelixisEXEL
$212.05M+14.7%
CTO
Citius Oncology, Inc.CTOR
-$26.61M-244%
Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
$293.1M+417%

Segments

By segment

See full
Reportable Segment-$16.7M-1.8%

Other financials

Income statement

See full
Revenue$57.5M+17.2%
Operating income-$12.5M-0.3%
EPS (diluted)-$0.020.0%

Balance sheet

See full
Cash & equivalents$64.5M-18.9%
Total debt$134.1M-0.3%
Total equity$218.6M-15.8%
Total assets$519.0M-6.5%

Cash flow

See full
Operating cash flow-$15.8M+42.3%
CapEx$206.0K+2.0%
Free cash flow-$43.8M-6.8%

Valuation

See full
Market cap$1.01B+13.8%
Enterprise value$1.08B+14.5%
P/S4.9×-180×

Profitability

See full
Operating margin-705.5%-351pp
Net margin-682.5%-339pp
FCF margin-734.4%-365pp

Returns & leverage

See full
Return on equity-28.3%-2.3pp
Debt / equity0.6×+0.1×
Current ratio6.9×-1.0×

Where this comes from

Reported directly by Geron in its filing.

Tagged under the XBRL concept us-gaap:NetIncomeLoss.

The source filing: Geron’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:41 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0000886744-26-000037
Line itemTHREE MONTHS ENDEDJUNE 30, 2026THREE MONTHS ENDEDJUNE 30, 2025SIX MONTHS ENDEDJUNE 30, 2026SIX MONTHS ENDEDJUNE 30, 2025
Total costs and operating expenses69,97661,490121,655117,797
Loss from operations(12,496)(12,454)(12,338)(29,158)
Interest income2,9714,6566,3929,808
Interest expense(7,146)(8,516)(14,293)(16,716)
Other income (expense), net(9)(61)(83)(144)
Net loss$(16,680)$(16,375)$(20,322)$(36,210)
Basic and diluted net loss per share$(0.02)$(0.02)$(0.03)$(0.05)
Weighted-average shares used in calculating basic and diluted net loss per share670,696666,170670,039666,039

ITEM 1. FINANCIAL STATEMENTS (UNAUDITED)

FAQ

What is Geron's net income?
Geron (GERN) reported net income of -$16.68M in Q2 2026.
How has Geron's net income changed year-over-year?
Geron's net income decreased by 1.9% year-over-year, from -$16.38M to -$16.68M.
What is the long-term trend for Geron's net income?
Over 4 years (2021 to 2025), Geron's net income has grown at a -7.9% compound annual growth rate (CAGR), from -$116.11M to -$83.5M.
What does net income mean?
The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.

Ask your AI about Geron's net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude